世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4022
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ナルコレプシー治療の市場動向
・企業の競争状況、市場シェア
・ナルコレプシー治療の種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）
・ナルコレプシー治療の用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発性ナルコレプシー、病状によるナルコレプシー、不特定ナルコレプシー）
・ナルコレプシー治療の北米市場規模2016-2027（アメリカ、カナダ）
・ナルコレプシー治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ナルコレプシー治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ナルコレプシー治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ナルコレプシー治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Teva Pharmaceutical、Takeda、Jazz Pharmaceuticals、Arena Pharmaceuticals、Graymark Healthcare、Ligand Pharmaceuticals）
・結論

Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep.
By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimulants, sodium oxybate, and antidepressants.

Market Analysis and Insights: Global Narcolepsy Treatment Market
The global Narcolepsy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Narcolepsy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Narcolepsy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Narcolepsy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Narcolepsy Treatment market.

Global Narcolepsy Treatment Scope and Market Size
Narcolepsy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sodium Oxybate
Antidepressants
Central Nervous System Stimulants
Others

Segment by Application
Primary Narcolepsy with Cataplexy
Primary Narcolepsy without Cataplexy
Narcolepsy Due to Medical Conditions
Unspecified Narcolepsy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva Pharmaceutical
Takeda
Jazz Pharmaceuticals
Arena Pharmaceuticals
Graymark Healthcare
Ligand Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sodium Oxybate
1.2.3 Antidepressants
1.2.4 Central Nervous System Stimulants
1.2.5 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Primary Narcolepsy with Cataplexy
1.3.3 Primary Narcolepsy without Cataplexy
1.3.4 Narcolepsy Due to Medical Conditions
1.3.5 Unspecified Narcolepsy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Narcolepsy Treatment Market Perspective (2016-2027)
2.2 Narcolepsy Treatment Growth Trends by Regions
2.2.1 Narcolepsy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Narcolepsy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Narcolepsy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Narcolepsy Treatment Industry Dynamic
2.3.1 Narcolepsy Treatment Market Trends
2.3.2 Narcolepsy Treatment Market Drivers
2.3.3 Narcolepsy Treatment Market Challenges
2.3.4 Narcolepsy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Treatment Players by Revenue
3.1.1 Global Top Narcolepsy Treatment Players by Revenue (2016-2021)
3.1.2 Global Narcolepsy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Narcolepsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Treatment Revenue
3.4 Global Narcolepsy Treatment Market Concentration Ratio
3.4.1 Global Narcolepsy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Treatment Revenue in 2020
3.5 Narcolepsy Treatment Key Players Head office and Area Served
3.6 Key Players Narcolepsy Treatment Product Solution and Service
3.7 Date of Enter into Narcolepsy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Narcolepsy Treatment Breakdown Data by Type
4.1 Global Narcolepsy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2022-2027)

5 Narcolepsy Treatment Breakdown Data by Application
5.1 Global Narcolepsy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Narcolepsy Treatment Market Size (2016-2027)
6.2 North America Narcolepsy Treatment Market Size by Type
6.2.1 North America Narcolepsy Treatment Market Size by Type (2016-2021)
6.2.2 North America Narcolepsy Treatment Market Size by Type (2022-2027)
6.2.3 North America Narcolepsy Treatment Market Size by Type (2016-2027)
6.3 North America Narcolepsy Treatment Market Size by Application
6.3.1 North America Narcolepsy Treatment Market Size by Application (2016-2021)
6.3.2 North America Narcolepsy Treatment Market Size by Application (2022-2027)
6.3.3 North America Narcolepsy Treatment Market Size by Application (2016-2027)
6.4 North America Narcolepsy Treatment Market Size by Country
6.4.1 North America Narcolepsy Treatment Market Size by Country (2016-2021)
6.4.2 North America Narcolepsy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Narcolepsy Treatment Market Size (2016-2027)
7.2 Europe Narcolepsy Treatment Market Size by Type
7.2.1 Europe Narcolepsy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Narcolepsy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Narcolepsy Treatment Market Size by Type (2016-2027)
7.3 Europe Narcolepsy Treatment Market Size by Application
7.3.1 Europe Narcolepsy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Narcolepsy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Narcolepsy Treatment Market Size by Application (2016-2027)
7.4 Europe Narcolepsy Treatment Market Size by Country
7.4.1 Europe Narcolepsy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Narcolepsy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Narcolepsy Treatment Market Size by Type
8.2.1 Asia-Pacific Narcolepsy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Narcolepsy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Narcolepsy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Narcolepsy Treatment Market Size by Application
8.3.1 Asia-Pacific Narcolepsy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Narcolepsy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Narcolepsy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Narcolepsy Treatment Market Size by Region
8.4.1 Asia-Pacific Narcolepsy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Narcolepsy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Narcolepsy Treatment Market Size (2016-2027)
9.2 Latin America Narcolepsy Treatment Market Size by Type
9.2.1 Latin America Narcolepsy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Narcolepsy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Narcolepsy Treatment Market Size by Type (2016-2027)
9.3 Latin America Narcolepsy Treatment Market Size by Application
9.3.1 Latin America Narcolepsy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Narcolepsy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Narcolepsy Treatment Market Size by Application (2016-2027)
9.4 Latin America Narcolepsy Treatment Market Size by Country
9.4.1 Latin America Narcolepsy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Narcolepsy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Narcolepsy Treatment Market Size by Type
10.2.1 Middle East & Africa Narcolepsy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Narcolepsy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Narcolepsy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Narcolepsy Treatment Market Size by Application
10.3.1 Middle East & Africa Narcolepsy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Narcolepsy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Narcolepsy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Narcolepsy Treatment Market Size by Country
10.4.1 Middle East & Africa Narcolepsy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Narcolepsy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Narcolepsy Treatment Introduction
11.1.4 Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2016-2021)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Narcolepsy Treatment Introduction
11.2.4 Takeda Revenue in Narcolepsy Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Details
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021)
11.3.5 Jazz Pharmaceuticals Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Narcolepsy Treatment Introduction
11.4.4 Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Graymark Healthcare
11.5.1 Graymark Healthcare Company Details
11.5.2 Graymark Healthcare Business Overview
11.5.3 Graymark Healthcare Narcolepsy Treatment Introduction
11.5.4 Graymark Healthcare Revenue in Narcolepsy Treatment Business (2016-2021)
11.5.5 Graymark Healthcare Recent Development
11.6 Ligand Pharmaceuticals
11.6.1 Ligand Pharmaceuticals Company Details
11.6.2 Ligand Pharmaceuticals Business Overview
11.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Introduction
11.6.4 Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021)
11.6.5 Ligand Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Narcolepsy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sodium Oxybate
Table 3. Key Players of Antidepressants
Table 4. Key Players of Central Nervous System Stimulants
Table 5. Key Players of Others
Table 6. Global Narcolepsy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Narcolepsy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Narcolepsy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Narcolepsy Treatment Market Share by Regions (2016-2021)
Table 10. Global Narcolepsy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Narcolepsy Treatment Market Share by Regions (2022-2027)
Table 12. Narcolepsy Treatment Market Trends
Table 13. Narcolepsy Treatment Market Drivers
Table 14. Narcolepsy Treatment Market Challenges
Table 15. Narcolepsy Treatment Market Restraints
Table 16. Global Narcolepsy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Narcolepsy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Treatment as of 2020)
Table 19. Ranking of Global Top Narcolepsy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Narcolepsy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Narcolepsy Treatment Product Solution and Service
Table 23. Date of Enter into Narcolepsy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Narcolepsy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Narcolepsy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Narcolepsy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Narcolepsy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Narcolepsy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Narcolepsy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Narcolepsy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Narcolepsy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Narcolepsy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Narcolepsy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Narcolepsy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Narcolepsy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Narcolepsy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Narcolepsy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Narcolepsy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Narcolepsy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Narcolepsy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Narcolepsy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Narcolepsy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Narcolepsy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Narcolepsy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Narcolepsy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Narcolepsy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Narcolepsy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Narcolepsy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Narcolepsy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Narcolepsy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Narcolepsy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Narcolepsy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Narcolepsy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Narcolepsy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Narcolepsy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Narcolepsy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Teva Pharmaceutical Company Details
Table 64. Teva Pharmaceutical Business Overview
Table 65. Teva Pharmaceutical Narcolepsy Treatment Product
Table 66. Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 67. Teva Pharmaceutical Recent Development
Table 68. Takeda Company Details
Table 69. Takeda Business Overview
Table 70. Takeda Narcolepsy Treatment Product
Table 71. Takeda Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 72. Takeda Recent Development
Table 73. Jazz Pharmaceuticals Company Details
Table 74. Jazz Pharmaceuticals Business Overview
Table 75. Jazz Pharmaceuticals Narcolepsy Treatment Product
Table 76. Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 77. Jazz Pharmaceuticals Recent Development
Table 78. Arena Pharmaceuticals Company Details
Table 79. Arena Pharmaceuticals Business Overview
Table 80. Arena Pharmaceuticals Narcolepsy Treatment Product
Table 81. Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 82. Arena Pharmaceuticals Recent Development
Table 83. Graymark Healthcare Company Details
Table 84. Graymark Healthcare Business Overview
Table 85. Graymark Healthcare Narcolepsy Treatment Product
Table 86. Graymark Healthcare Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 87. Graymark Healthcare Recent Development
Table 88. Ligand Pharmaceuticals Company Details
Table 89. Ligand Pharmaceuticals Business Overview
Table 90. Ligand Pharmaceuticals Narcolepsy Treatment Product
Table 91. Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2016-2021) & (US$ Million)
Table 92. Ligand Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Sodium Oxybate Features
Figure 3. Antidepressants Features
Figure 4. Central Nervous System Stimulants Features
Figure 5. Others Features
Figure 6. Global Narcolepsy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Primary Narcolepsy with Cataplexy Case Studies
Figure 8. Primary Narcolepsy without Cataplexy Case Studies
Figure 9. Narcolepsy Due to Medical Conditions Case Studies
Figure 10. Unspecified Narcolepsy Case Studies
Figure 11. Narcolepsy Treatment Report Years Considered
Figure 12. Global Narcolepsy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Narcolepsy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Narcolepsy Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Narcolepsy Treatment Market Share by Regions (2022-2027)
Figure 16. Global Narcolepsy Treatment Market Share by Players in 2020
Figure 17. Global Top Narcolepsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Narcolepsy Treatment Revenue in 2020
Figure 19. Global Narcolepsy Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Narcolepsy Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Narcolepsy Treatment Market Share by Type (2016-2027)
Figure 23. North America Narcolepsy Treatment Market Share by Application (2016-2027)
Figure 24. North America Narcolepsy Treatment Market Share by Country (2016-2027)
Figure 25. United States Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Narcolepsy Treatment Market Share by Type (2016-2027)
Figure 29. Europe Narcolepsy Treatment Market Share by Application (2016-2027)
Figure 30. Europe Narcolepsy Treatment Market Share by Country (2016-2027)
Figure 31. Germany Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Narcolepsy Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Narcolepsy Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Narcolepsy Treatment Market Share by Region (2016-2027)
Figure 41. China Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Narcolepsy Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Narcolepsy Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Narcolepsy Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Narcolepsy Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Narcolepsy Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Narcolepsy Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Narcolepsy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 62. Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 64. Graymark Healthcare Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 65. Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のナルコレプシー市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Market Size, Status and Forecast 2021-2027
QYR2104Z4020 2021年4月 98Pages
QYResearch社発行の本調査資料では、ナルコレプシーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（日中眠気、脱力発作、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のナルコレプシー治療薬市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4021 2021年4月 91Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他）、用途別市場規模（脱力...

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界のジフテリア治療市場規模・現状・予測（2021年-2027年）

Global Diphtheria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1902 2021年4月 95Pages
QYResearch社発行の本調査資料では、ジフテリア治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）、用途別市場規模（抗毒素、抗生物質、その他）、主...

世界の水疱性類天疱瘡治療市場規模・現状・予測（2021年-2027年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1030 2021年4月 97Pages
QYResearch社発行の本調査資料では、水疱性類天疱瘡治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメ...

世界の裂肛治療市場規模・現状・予測（2021年-2027年）

Global Anal Fissure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0309 2021年4月 91Pages
QYResearch社発行の本調査資料では、裂肛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所ニトログリセリン、カルシウムチャネル遮断薬、便軟化剤、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリ...

世界の軟骨肉腫治療市場規模・現状・予測（2021年-2027年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1305 2021年4月 99Pages
QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界のハンセン病治療市場規模・現状・予測（2021年-2027年）

Global Leprosy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3400 2021年4月 91Pages
QYResearch社発行の本調査資料では、ハンセン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のナルコレプシー治療薬市場規模・現状・予測（2021年-2027年） Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time. Market Analysis and Insights: Global Narcolepsy Therapeutics Mark…
世界のナルコレプシー市場規模・現状・予測（2021年-2027年） Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at …
世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. Market Analysis and Insights: Global Central Nervous System Treatment Market The global Central Nervous System Treatment m…
世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Immunodeficiency Diseases Treatment Market The global Primary Immunodeficiency Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …